‘Constructive Tone’ Now Emerging Among World Trade Organization Members On IP Waiver for COVID Health Products 07/10/2021 Elaine Ruth Fletcher Discussions over a controversial World Trade Organization waiver on intellectual property related to COVID vaccines, treatments and other tools, have become more “constructive” said a senior WTO spokesman on Thursday, in a press briefing on the first day of the WTO’s two-day General Council meeting. There has been a “subtle shifting in the direction of […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> As India Lifts its Vaccine Export Ban – will 600 Million India-made Doses of J&J Vaccine be Shipped to Rich Western Countries? 24/09/2021 Vidya Kirshnan In the coming months, 600 million doses of single-shot Johnson & Johnson vaccines, manufactured in Hyderabad, are likely to be exported to Europe or the United States, at a time when India grapples with vaccinating its own citizens. Civil-society organisations are concerned that millions of doses of the COVID-19 vaccine may end up in the […] Continue reading -> REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> World Leaders Call on Future German Chancellor to Support TRIPS Waiver 15/09/2021 Kerry Cullinan More than 140 former heads of state and Nobel laureates have called on the three candidates in line to be the next German chancellor to declare themselves in favour of waiving intellectual property on COVID-19 vaccines and transferring vaccine technologies. Germany is leading the European Commission’s refusal to accept the so-called TRIPS waiver proposal put […] Continue reading -> ‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> As India Lifts its Vaccine Export Ban – will 600 Million India-made Doses of J&J Vaccine be Shipped to Rich Western Countries? 24/09/2021 Vidya Kirshnan In the coming months, 600 million doses of single-shot Johnson & Johnson vaccines, manufactured in Hyderabad, are likely to be exported to Europe or the United States, at a time when India grapples with vaccinating its own citizens. Civil-society organisations are concerned that millions of doses of the COVID-19 vaccine may end up in the […] Continue reading -> REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> World Leaders Call on Future German Chancellor to Support TRIPS Waiver 15/09/2021 Kerry Cullinan More than 140 former heads of state and Nobel laureates have called on the three candidates in line to be the next German chancellor to declare themselves in favour of waiving intellectual property on COVID-19 vaccines and transferring vaccine technologies. Germany is leading the European Commission’s refusal to accept the so-called TRIPS waiver proposal put […] Continue reading -> ‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> As India Lifts its Vaccine Export Ban – will 600 Million India-made Doses of J&J Vaccine be Shipped to Rich Western Countries? 24/09/2021 Vidya Kirshnan In the coming months, 600 million doses of single-shot Johnson & Johnson vaccines, manufactured in Hyderabad, are likely to be exported to Europe or the United States, at a time when India grapples with vaccinating its own citizens. Civil-society organisations are concerned that millions of doses of the COVID-19 vaccine may end up in the […] Continue reading -> REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> World Leaders Call on Future German Chancellor to Support TRIPS Waiver 15/09/2021 Kerry Cullinan More than 140 former heads of state and Nobel laureates have called on the three candidates in line to be the next German chancellor to declare themselves in favour of waiving intellectual property on COVID-19 vaccines and transferring vaccine technologies. Germany is leading the European Commission’s refusal to accept the so-called TRIPS waiver proposal put […] Continue reading -> ‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As India Lifts its Vaccine Export Ban – will 600 Million India-made Doses of J&J Vaccine be Shipped to Rich Western Countries? 24/09/2021 Vidya Kirshnan In the coming months, 600 million doses of single-shot Johnson & Johnson vaccines, manufactured in Hyderabad, are likely to be exported to Europe or the United States, at a time when India grapples with vaccinating its own citizens. Civil-society organisations are concerned that millions of doses of the COVID-19 vaccine may end up in the […] Continue reading -> REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> World Leaders Call on Future German Chancellor to Support TRIPS Waiver 15/09/2021 Kerry Cullinan More than 140 former heads of state and Nobel laureates have called on the three candidates in line to be the next German chancellor to declare themselves in favour of waiving intellectual property on COVID-19 vaccines and transferring vaccine technologies. Germany is leading the European Commission’s refusal to accept the so-called TRIPS waiver proposal put […] Continue reading -> ‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> World Leaders Call on Future German Chancellor to Support TRIPS Waiver 15/09/2021 Kerry Cullinan More than 140 former heads of state and Nobel laureates have called on the three candidates in line to be the next German chancellor to declare themselves in favour of waiving intellectual property on COVID-19 vaccines and transferring vaccine technologies. Germany is leading the European Commission’s refusal to accept the so-called TRIPS waiver proposal put […] Continue reading -> ‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Leaders Call on Future German Chancellor to Support TRIPS Waiver 15/09/2021 Kerry Cullinan More than 140 former heads of state and Nobel laureates have called on the three candidates in line to be the next German chancellor to declare themselves in favour of waiving intellectual property on COVID-19 vaccines and transferring vaccine technologies. Germany is leading the European Commission’s refusal to accept the so-called TRIPS waiver proposal put […] Continue reading -> ‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Posts navigation Older postsNewer posts